Peripheral blood leukocytes as a surrogate marker for cisplatin drug resistance: studies of adduct levels and the repair gene ERCC1.
Parker
R J
RJ
Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.
Poirier
M C
MC
Bostick-Bruton
F
F
Vionnet
J
J
Bohr
V A
VA
Reed
E
E
D000818:Animals; D016190:Carboplatin / Q000627:therapeutic use*; D002460:Cell Line; D002945:Cisplatin / Q000494:pharmacology / Q000627:therapeutic use*; D004247:DNA / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D004249:DNA Damage; D004260:DNA Repair; D004351:Drug Resistance / Q000235:genetics; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D012313:RNA / Q000235:genetics / Q000302:isolation & purification
D012313:RNA; D004247:DNA; D016190:Carboplatin; D002945:Cisplatin